Dr. Cheryl Arrowsmith, Senior Scientist, Princess Margaret Cancer Centre (IMAGE)

University Health Network

Dr. Cheryl Arrowsmith, Senior Scientist, Princess Margaret Cancer Centre

Caption

Dr. Cheryl Arrowsmith and team found a promising approach with a protein biomarker that could potentially identify the best patients for more precise, targeted therapy in the future for triple negative breast cancer.

Credit

The Princess Margaret Cancer Foundation

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.